It’s Time to Talk
We’re here to help you have rewarding conversations with your patients about their care goals, preferences, and wishes near the end of life.Download Our Tipsheet
Your Patients Are Ready
VITAS Healthcare commissioned nationwide studies in 2021, 2022, and 2023 that found many Americans are open to talking about their wishes and values for end-of-life care.
The studies of 1,000 U.S. adults found that:
- More than half of people (56%) say they know what kind of medical treatment they do and do not want at end of life. However, only about one in four (22%) say they have formally documented their wishes and values for end-of-life care.
- Only about half of people (49%) know where to find information about documenting their end-of-life wishes and values.
- People feel most comfortable having advance care planning conversations with their partner/spouse. However, clinicians play an important role in advance care planning, especially for communities of color and younger Americans.
- Hispanic (12%) and Asian (14%) Americans prefer to speak with a healthcare specialist (compared to 6% in general).
- Young people (18-34) were most likely to engage in end-of-life care planning if a trusted healthcare professional asked them to, at 32% versus 22% for those ages 35-54 and 18% for those ages 55 and older.
You May Also Like
When a patient’s disease is incurable, or when life-prolonging treatment becomes ineffective, HCPs are confronted with the stressful task of communicating to patients that the end of life is near.
The trick to knowing what your chronically ill patients want near the end of life is to have the goals-of-care conversation early, regularly and matter-of-factly.
VITAS provides a free hospice discussion guide for your patients and their loved ones, so they can agree on plans that align with their goals, needs, and wishes.
Physicians, physician assistants and nurse practitioners can bill Medicare for the time they spend in face-to-face discussions about advance care planning (ACP) and end-of-life care decisions with their patients or their patient’s beneficiaries/surrogate.